
Glykos M 80mg/500mg Tablet SR
Marketer
Elkos Healthcare Pvt Ltd
Salt Composition
Gliclazide (80mg) + Metformin (500mg)
Overview Glykos M 80mg/500mg Tablet SR
DiabetaComb 80mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. DiabetaComb 80mg/500mg ER Tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication, even with controlled blood sugar, as discontinuation without consulting your doctor can lead to elevated blood glucose and potentially serious complications, including kidney impairment, vision loss, neuropathy, and limb amputation. Remember, it's crucial to combine this medication with a healthy diet, regular physical activity, and weight management as recommended by your healthcare provider for comprehensive diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation, and vomiting. Learn to recognize and treat hypoglycemia; maintain regular mealtimes and carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your physician of any history of heart problems before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Uses of Glykos M 80mg/500mg Tablet SR
Diabetes mellitus, type 2
Major Benefits of Glykos M 80mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glykos M 80mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Glykos M 80mg/500mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Dizziness
- Diarrhea
- Upper respiratory tract infection
- Nausea
- Flatulence
- Constipation
How to use Glykos M 80mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Glykos M 80mg/500mg Sustained-Release Tablets should be taken with meals.
How Glykos M 80mg/500mg Tablet SR works:
Glykos M SR tablets (80mg/500mg) contain gliclazide and metformin, two medications used to manage blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glykos M 80mg/500mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Glykos M 80mg/500mg tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glykos M 80mg/500mg tablets are likely unsuitable for breastfeeding mothers. Preliminary human evidence indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glykos M 80mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glykos M 80mg/500mg SR tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Individuals with liver impairment should use Glykos M 80mg/500mg Tablet SR cautiously. Dosage modification of Glykos M 80mg/500mg Tablet SR might be necessary. Physician consultation is advised. A reduced initial dose of Glykos M 80mg/500mg Tablet SR is typically prescribed for those with mild to moderate liver disease; it's not recommended for patients exhibiting severe hepatic dysfunction.
What if you forget to take Glykos M 80mg/500mg Tablet SR :
Should you forget a Glykos M 80mg/500mg SR Tablet dose, administer it promptly. However, near the time for your next scheduled dose, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Glykos M 80mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
